Ahrn B, Masmiquel L, Kumar H et al (2017) Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial
At Vytal Health, weve seen many patients find relief through a functional medicine approach that includes microdosing GLP-1 medications , like a compounded version of tirzepatide, alongside gut repair, hormone balancing, and nervous-system support
No clinical trial has tested cagrilintide + retatrutide together
Symptoms may include nausea, diarrhea, vomiting, stomach pain, and low-grade fever, among others
Photo By David Shankbone David Shankbone, CC BY 3.0,